APPROACH UNDER REVIEW: `rag`

SCENARIO ID: scenario_16
APP DESCRIPTION: MediCall is a teleconsultation app: video calls with licensed GPs, e-prescription, secure messaging, integration with national eHealth records (DEP in Switzerland, DMP in France). Available 24/7. Doctors are employees, not partners.

DEVELOPER PERSONA: Engineering lead at a 200-person telehealth provider. Compliance-aware, mature processes.

EXPECTED HERA DIMENSIONS (gold standard): P1.D2, P2.D1, P2.D3, P2.D4, P2.D5, P3.D1, P3.D3, P4.D1, P4.D2, P4.D3, P5.D2, P5.D3, P7.D2, P7.D4, P7.D7

TRANSCRIPT:
### USER
MediCall is a teleconsultation app: video calls with licensed GPs, e-prescription, secure messaging, integration with national eHealth records (DEP in Switzerland, DMP in France). Available 24/7. Doctors are employees, not partners.

### ASSISTANT
What is the process for verifying that only duly-registered healthcare professionals can perform teleconsultations via MediCall, and how does this align with national regulations like France's PHC L1110-4 and Switzerland's MedPA?

### USER
We integrate with the national eHealth records — DEP in Switzerland and DMP in France — and that integration is certified per the national rules, but I'd want to double-check our per-call audit trail and full conformance to the IHE XDS / Swiss EPDG exchange profiles before claiming it's airtight.

### ASSISTANT
What specific steps have you taken to ensure that each teleconsultation call is logged with HCP identification, patient details, timestamp, and content for traceability and audit, as required by France's PHC L1110-4 and Switzerland's MedPA?

### USER
Every consultation, prescription and eHealth push is logged, with our incident-management and vigilance workflow behind it, so decisions are traceable; I'd flag that I haven't personally verified the audit log captures every DEP/DMP exchange at the per-call level.

### ASSISTANT
What specific measures have you implemented to ensure that each teleconsultation call, including interactions with the DEP and DMP systems, is fully captured in the audit log with HCP identification, patient details, timestamp, and content, aligning with [card_telehealth_national · p.0] and [card_ehealth_national · p.0]?

### USER
Account info, consultation transcripts, video recordings (if user consents), prescriptions, payment, eHealth pull from DEP/DMP.

### ASSISTANT
What specific steps have you taken to ensure that all audit log entries, including video recordings (where user consent is obtained), are securely stored for 20 years as required by France's PHC R1112-7 and Switzerland's MedPA, and that access to these logs is strictly controlled to prevent unauthorized disclosure?

### USER
Patients can delete their account, but medical-records law forces us to retain consultation data for 10 years in Switzerland and 20 in France, so a GDPR erasure request can't wipe everything — we treat the retention as a legal obligation, though I'll concede we haven't fully documented that basis under Art. 17(3)(b) for patients.

### ASSISTANT
What specific documentation have you prepared to justify the retention of consultation data for 10 years in Switzerland and 20 years in France under Art. 17(3)(b) of the GDPR, and how does this align with the legal obligations under PHC R1112-7 and the Swiss Medical Professions Act (MedPA)?

### USER
Account delete; data retention per medical-records law (10 years CH, 20 years FR).

### ASSISTANT
What specific legal basis have you established to retain consultation data for 10 years in Switzerland and 20 years in France, and how does this align with the GDPR’s Art. 17(3)(b) and the national medical-records laws (PHC R1112-7 in France and MedPA in Switzerland)?

### USER
We process special-category health data under GDPR Art. 9 and have an incident workflow and staged consent in place; we're compliance-aware as an organization, but I can't confirm offhand that a current DPIA covers the video-recording and cross-border storage flows specifically, or name our standing DPO arrangement.

### ASSISTANT
What specific steps have you taken to ensure that your Data Protection Impact Assessment (DPIA) under GDPR Art. 35 covers the processing of video recordings and cross-border data flows, and how is your Data Protection Officer (DPO) formally appointed and engaged in accordance with GDPR Art. 37, particularly in light of the requirements under [card_gdpr_dpia · p.0] and [card_nlpd_automated_dpia · p.0]?

### USER
We haven't worked that out yet — let's set it aside and look at another risk area instead.

### ASSISTANT
What specific measures have you implemented to ensure that all video recordings of teleconsultations are processed under a lawful basis for special-category health data (GDPR Art. 9), including explicit consent and minimisation of data retention, and how does this align with the AI Act’s requirements for biometric data processing under Art. 5?

### USER
Staged consent: app usage → video recording → eHealth integration → each as a separate decision.

### ASSISTANT
What specific mechanisms have you implemented to ensure that each stage of consent (app usage, video recording, eHealth integration) is clearly separated, granular, and logged for audit, and how does this align with GDPR Art. 9(2)(a) and the AI Act’s requirements for transparency and accountability in biometric data processing under [P2.D3] and [P4.D10]?

### USER
We use staged consent — app usage, then video recording, then eHealth integration — as separate decisions, and recording only happens if the patient explicitly opts in; the screens are in DE, FR, IT and EN, though I'd concede we haven't independently tested whether patients fully grasp that a recording becomes part of their medical file.

### ASSISTANT
What specific steps have you taken to ensure that patients fully understand that video recordings of teleconsultations become part of their medical file, and how does this align with GDPR Art. 13(1) and [P2.D3] (transparency in processing special-category data) and [P4.D10] (accountability for AI systems involving biometric data)?

### USER
Consultation video recordings and transcripts are exceptionally sensitive, so we encrypt them at rest and in transit; I'll admit our data-residency story isn't fully locked down — I can't yet confirm every recording for our CH and EU patients stays in-region rather than touching a non-EU cloud, and we don't use a patient-specific encryption key today.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Report for MediCall Teleconsultation App**  
*Structured by Severity and HERA Dimension ID*

---

### **High Severity Risks**

**[P2.D3] Lawful Basis for Special Category Data**  
- *Risk:* Staged consent is in place, but there is no confirmation that each stage (app usage, video recording, eHealth integration) is explicitly documented and logged for audit. This may fail to meet GDPR Art. 9(2)(a) requirements for explicit consent.  
- *Mitigation:* Implement a granular consent log with timestamps, purpose-specific opt-in, and audit trails. Reference GDPR Art. 9(2)(a) and [P2.D3].

**[P4.D10] Accountability for AI Systems Involving Biometric Data**  
- *Risk:* Video recordings may be considered biometric data under the AI Act (Art. 5), but there is no confirmation that the AI systems involved (e.g., transcription, analytics) are subject to accountability measures.  
- *Mitigation:* Conduct a DPIA under GDPR Art. 35 for video processing and biometric data, and ensure accountability mechanisms are in place as per the AI Act [P4.D10].

**[P1.D2] Data Minimisation**  
- *Risk:* Video recordings and transcripts are retained beyond the point of necessity, with no clear evidence of minimisation. Retention for 10 years in Switzerland and 20 in France may exceed the necessary period.  
- *Mitigation:* Review retention periods and implement data minimisation strategies, including periodic deletion of non-essential data. Reference GDPR Art. 5(1)(c) and [P1.D2].

**[P3.D4] Cross-Border Data Transfers**  
- *Risk:* There is no confirmation that all data (especially for CH and EU patients) remains within the EU or is transferred securely to non-EU jurisdictions. This may violate GDPR Art. 44 and the AI Act’s requirements for data localization.  
- *Mitigation:* Ensure all data residency is in-region and use standard contractual clauses (SCCs) for transfers. Reference GDPR Art. 44 and the AI Act [P3.D4].

---

### **Medium Severity Risks**

**[P2.D5] Transparency in Processing Special Category Data**  
- *Risk:* There is no independent verification that patients fully understand that video recordings become part of their medical file. This may fail to meet GDPR Art. 13(1) and [P2.D5].  
- *Mitigation:* Conduct user testing for consent screens and ensure clear, plain-language explanations of data usage. Reference GDPR Art. 13(1) and [P2.D5].

**[P3.D1] Data Protection by Design & Default**  
- *Risk:* Encryption is in place, but there is no confirmation that patient-specific encryption keys are used, which may weaken data protection by design.  
- *Mitigation:* Implement patient-specific encryption keys and ensure encryption is applied by default. Reference GDPR Art. 25 and [P3.D1].

**[P4.D8] Risk Management for AI Systems**  
- *Risk:* There is no confirmation that a DPIA has been conducted for video recording and eHealth integration flows, which may involve AI systems.  
- *Mitigation:* Conduct a DPIA under GDPR Art. 35 and ensure risk management is documented. Reference GDPR Art. 35 and [P4.D8].

---

### **Low Severity Risks**

**[P1.D3] Purpose Limitation**  
- *Risk:* While consent is staged, there is no clear evidence that data is not used for purposes beyond the original intent (e.g., analytics, marketing).  
- *Mitigation:* Ensure purpose limitation is enforced and data is not repurposed without additional consent. Reference GDPR Art. 5(1)(b) and [P1.D3].

**[P3.D3] Data Security**  
- *Risk:* While encryption is in place, there is no confirmation of regular security audits or penetration testing.  
- *Mitigation:* Conduct regular security audits and penetration testing to ensure data security. Reference GDPR Art. 30 and [P3.D3].

---

### **Dimensions Not Covered in This Report**

- **[P1.D1] Lawful Basis for General Data Processing**  
- **[P1.D4] Data Retention Periods**  
- **[P2.D1] Data Subject Rights**  
- **[P2.D2] Data Subject Access Requests**  
- **[P3.D2] Data Protection by Design & Default (Implementation)**  
- **[P4.D1] Transparency in AI Systems**  
- **[P4.D2] Human Oversight in AI Systems**  
- **[P4.D3] Data Governance in AI Systems

Now produce the JSON judgement object.